Identification of novel regulators of Zalcitabine-Induced neuropathic pain

Neuropathic pain is one of the foremost adverse effects that worsens quality of life for patients undergoing an antiretroviral treatment. Currently, there are no effective analgesics for relieving it; thus, there is an urgent need to develop novel treatments for neuropathic pain. Previously, we desc...

Descripción completa

Detalles Bibliográficos
Autores: Martínez Rodríguez, Antón Leandro, Brea Floriani, José Manuel, Domínguez Medina, Eduardo, Varela Liste, María José, Cimadevila Fondevila, Marta, Allegue Toscano, Catarina, Cruz Guerrero, Raquel, Monroy, Xavier, Merlos, Manuel, Burgueño, Javier, Carracedo Álvarez, Ángel, Loza García, María Isabel
Tipo de recurso: artículo
Fecha de publicación:2021
País:España
Institución:Universidad de Santiago de Compostela (USC)
Repositorio:Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
Idioma:inglés
OAI Identifier:oai:minerva.usc.gal:10347/45062
Acceso en línea:https://hdl.handle.net/10347/45062
Access Level:acceso abierto
Palabra clave:Neuropathic pain
Antiretrovirals
Hyperexcitability,
Alcium transients
Transcriptomic assays
Adverse effects
id ES_6d8700137458ab8de8fc4d4bfefa67c3
oai_identifier_str oai:minerva.usc.gal:10347/45062
network_acronym_str ES
network_name_str España
repository_id_str
spelling Identification of novel regulators of Zalcitabine-Induced neuropathic painMartínez Rodríguez, Antón LeandroBrea Floriani, José ManuelDomínguez Medina, EduardoVarela Liste, María JoséCimadevila Fondevila, MartaAllegue Toscano, CatarinaCruz Guerrero, RaquelMonroy, XavierMerlos, ManuelBurgueño, JavierCarracedo Álvarez, ÁngelLoza García, María IsabelNeuropathic painAntiretroviralsHyperexcitability,Alcium transientsTranscriptomic assaysAdverse effectsNeuropathic pain is one of the foremost adverse effects that worsens quality of life for patients undergoing an antiretroviral treatment. Currently, there are no effective analgesics for relieving it; thus, there is an urgent need to develop novel treatments for neuropathic pain. Previously, we described and validated F11 cells as a model of DRG (dorsal root ganglia) neurons. In the current work, we employed F11 cells to identify regulators of antiretroviral-induced neuropathic pain combining functional and transcriptomic analysis. The antiretroviral zalcitabine (ddC) increased the excitability of differentiated F11 cells associated with calcium signaling without morphological changes in the neuronal phenotype, mimicking the observed increase of painful signaling in patients suffering from antiretroviral-induced neuropathic pain. Employing RNA sequencing, we observed that zalcitabine treatment upregulated genes related with oxidative stress and calcium homeostasis. The functional impact of the transcriptomic changes was explored, finding that the exposure to zalcitabine significantly increased intracellular oxidative stress and reduced store-operated calcium entry (SOCE). Because the functional and transcriptomic evidence points toward fundamental changes in calcium signaling and oxidative stress upon zalcitabine exposure, we identified that NAD(P)H quinone dehydrogenase and the sarcoplasmic/endoplasmic reticulum calcium ATPase 3 were involved in zalcitabine-induced hyperexcitability of F11 cells. Overexpression of those genes increases the calcium-elicited hyperexcitability response and reduces SOCE, as well as increases intracellular ROS levels. These data do not only mimic the effects of zalcitabine but also highlight the relevance of oxidative stress and of calcium-mediated signaling in antiretroviral-induced hyperexcitability of sensory neurons, shedding light on new therapeutic targets for antiviral-induced neuropathic painACS PublicationsUniversidade de Santiago de Compostela. Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CiMUS)Universidade de Santiago de Compostela. Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéutica20212021-06-2920212021-06-29journal articlehttp://purl.org/coar/resource_type/c_6501VoRhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleapplication/pdfhttps://hdl.handle.net/10347/45062reponame:Minerva. Repositorio Institucional de la Universidad de Santiago de Compostelainstname:Universidad de Santiago de Compostela (USC)InglésengAgencia Estatal de Investigación http://dx.doi.org/10.13039/501100011033 Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 RTC-2015-4207-1 Desarrollo de Modelos Fenotípicos In Vitro de Dolor y su Aplicación al Cribado de Compuestos de Alto Rendimiento (High-Throughput Screening)open accesshttp://purl.org/coar/access_right/c_abf2© 2021 The Authors. Published by American Chemical Society. This publication is licensed under CC-BY-NC-ND 4.0http://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccessoai:minerva.usc.gal:10347/450622026-06-15T12:47:27Z
dc.title.none.fl_str_mv Identification of novel regulators of Zalcitabine-Induced neuropathic pain
title Identification of novel regulators of Zalcitabine-Induced neuropathic pain
spellingShingle Identification of novel regulators of Zalcitabine-Induced neuropathic pain
Martínez Rodríguez, Antón Leandro
Neuropathic pain
Antiretrovirals
Hyperexcitability,
Alcium transients
Transcriptomic assays
Adverse effects
title_short Identification of novel regulators of Zalcitabine-Induced neuropathic pain
title_full Identification of novel regulators of Zalcitabine-Induced neuropathic pain
title_fullStr Identification of novel regulators of Zalcitabine-Induced neuropathic pain
title_full_unstemmed Identification of novel regulators of Zalcitabine-Induced neuropathic pain
title_sort Identification of novel regulators of Zalcitabine-Induced neuropathic pain
dc.creator.none.fl_str_mv Martínez Rodríguez, Antón Leandro
Brea Floriani, José Manuel
Domínguez Medina, Eduardo
Varela Liste, María José
Cimadevila Fondevila, Marta
Allegue Toscano, Catarina
Cruz Guerrero, Raquel
Monroy, Xavier
Merlos, Manuel
Burgueño, Javier
Carracedo Álvarez, Ángel
Loza García, María Isabel
author Martínez Rodríguez, Antón Leandro
author_facet Martínez Rodríguez, Antón Leandro
Brea Floriani, José Manuel
Domínguez Medina, Eduardo
Varela Liste, María José
Cimadevila Fondevila, Marta
Allegue Toscano, Catarina
Cruz Guerrero, Raquel
Monroy, Xavier
Merlos, Manuel
Burgueño, Javier
Carracedo Álvarez, Ángel
Loza García, María Isabel
author_role author
author2 Brea Floriani, José Manuel
Domínguez Medina, Eduardo
Varela Liste, María José
Cimadevila Fondevila, Marta
Allegue Toscano, Catarina
Cruz Guerrero, Raquel
Monroy, Xavier
Merlos, Manuel
Burgueño, Javier
Carracedo Álvarez, Ángel
Loza García, María Isabel
author2_role author
author
author
author
author
author
author
author
author
author
author
dc.contributor.none.fl_str_mv Universidade de Santiago de Compostela. Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CiMUS)
Universidade de Santiago de Compostela. Departamento de Farmacoloxía, Farmacia e Tecnoloxía Farmacéutica

dc.subject.none.fl_str_mv Neuropathic pain
Antiretrovirals
Hyperexcitability,
Alcium transients
Transcriptomic assays
Adverse effects
topic Neuropathic pain
Antiretrovirals
Hyperexcitability,
Alcium transients
Transcriptomic assays
Adverse effects
description Neuropathic pain is one of the foremost adverse effects that worsens quality of life for patients undergoing an antiretroviral treatment. Currently, there are no effective analgesics for relieving it; thus, there is an urgent need to develop novel treatments for neuropathic pain. Previously, we described and validated F11 cells as a model of DRG (dorsal root ganglia) neurons. In the current work, we employed F11 cells to identify regulators of antiretroviral-induced neuropathic pain combining functional and transcriptomic analysis. The antiretroviral zalcitabine (ddC) increased the excitability of differentiated F11 cells associated with calcium signaling without morphological changes in the neuronal phenotype, mimicking the observed increase of painful signaling in patients suffering from antiretroviral-induced neuropathic pain. Employing RNA sequencing, we observed that zalcitabine treatment upregulated genes related with oxidative stress and calcium homeostasis. The functional impact of the transcriptomic changes was explored, finding that the exposure to zalcitabine significantly increased intracellular oxidative stress and reduced store-operated calcium entry (SOCE). Because the functional and transcriptomic evidence points toward fundamental changes in calcium signaling and oxidative stress upon zalcitabine exposure, we identified that NAD(P)H quinone dehydrogenase and the sarcoplasmic/endoplasmic reticulum calcium ATPase 3 were involved in zalcitabine-induced hyperexcitability of F11 cells. Overexpression of those genes increases the calcium-elicited hyperexcitability response and reduces SOCE, as well as increases intracellular ROS levels. These data do not only mimic the effects of zalcitabine but also highlight the relevance of oxidative stress and of calcium-mediated signaling in antiretroviral-induced hyperexcitability of sensory neurons, shedding light on new therapeutic targets for antiviral-induced neuropathic pain
publishDate 2021
dc.date.none.fl_str_mv 2021
2021-06-29
2021
2021-06-29
dc.type.none.fl_str_mv journal article
http://purl.org/coar/resource_type/c_6501
VoR
http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.openaire.fl_str_mv info:eu-repo/semantics/article
format article
dc.identifier.none.fl_str_mv https://hdl.handle.net/10347/45062
url https://hdl.handle.net/10347/45062
dc.language.none.fl_str_mv Inglés
eng
language_invalid_str_mv Inglés
language eng
dc.relation.none.fl_str_mv Agencia Estatal de Investigación http://dx.doi.org/10.13039/501100011033 Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 RTC-2015-4207-1 Desarrollo de Modelos Fenotípicos In Vitro de Dolor y su Aplicación al Cribado de Compuestos de Alto Rendimiento (High-Throughput Screening)
dc.rights.none.fl_str_mv open access
http://purl.org/coar/access_right/c_abf2
http://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.openaire.fl_str_mv info:eu-repo/semantics/openAccess
rights_invalid_str_mv open access
http://purl.org/coar/access_right/c_abf2
http://creativecommons.org/licenses/by-nc-nd/4.0/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv ACS Publications
publisher.none.fl_str_mv ACS Publications
dc.source.none.fl_str_mv reponame:Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
instname:Universidad de Santiago de Compostela (USC)
instname_str Universidad de Santiago de Compostela (USC)
reponame_str Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
collection Minerva. Repositorio Institucional de la Universidad de Santiago de Compostela
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869410358903439360
score 15,811543